Tricida, Inc. is a pharmaceutical company, which engages in the development and commercialization of orally administered polymer drugs for chronic kidney diseases. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in Sacramento, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company